Skip to main content
Clinical Trials/NCT00795015
NCT00795015CompletedPhase 4

Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With an Intravenous Insulin Infusion

Rush University Medical Center1 site in 1 country93 target enrollmentStarted: April 2006Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
93
Locations
1
Primary Endpoint
Percent of blood glucose values in the target range 80-120 mg/dl

Study Overview

Brief Summary

The investigators are testing whether a written protocol or a computerized program can more effectively control blood glucose after surgery.

Detailed Description

In 2002 we adapted the protocol described by Van den Berghe et al. for use in our own surgical intensive care unit (SICU) with a target blood glucose range from 80 to 120mg/dL. After five years of implementation, we were able to achieve a mean BG of 117 mg/dL in the SICU. 2% of glucose values were <60 mg/dL in the SICU. Given the concern of safety while optimizing glycemic control, we investigated the etiologies for these hypoglycemic episodes and have found two frequent risk factors; the failure to consistently measure blood glucose every hour and in patients with end stage renal failure.

We will investigate whether a computer-based algorithm for the titration of IV insulin will translate to better clinical outcomes and less hypoglycemia. Therefore, we will conduct a prospective randomized trial comparing the Glucommander, a computer-based algorithm with our Van den Berghe protocol for titration of IV insulin in patients after cardiovascular or transplant surgery. This computer based algorithm was invented in 1984 in Atlanta by Dr. Davidson and Dr. Steed who have used it in a variety of applications of IV insulin.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •s/p open heart or kidney or liver transplant surgery

Exclusion Criteria

  • •admission blood glucose less than 120 mg/dl

Arms & Interventions

leuven

Active Comparator

these patients had their IV insulin controlled by using the protocol adapted from van den Berghe et al. University of Leuven, Belgium, NEJM Nov. 2001

Intervention: insulin regular IV infusion (Drug)

leuven

Active Comparator

these patients had their IV insulin controlled by using the protocol adapted from van den Berghe et al. University of Leuven, Belgium, NEJM Nov. 2001

Intervention: IV insulin infusion (Drug)

glucommander

Active Comparator

these subjects had IV insulin controlled by a computer program called the glucommander described by Davidson, P et al Diabetes Care Oct. 2005

Intervention: insulin regular IV infusion (Drug)

glucommander

Active Comparator

these subjects had IV insulin controlled by a computer program called the glucommander described by Davidson, P et al Diabetes Care Oct. 2005

Intervention: IV insulin infusion (Drug)

Outcomes

Primary Outcomes

Percent of blood glucose values in the target range 80-120 mg/dl

Time Frame: first 200 hours post-op in the ICU

Secondary Outcomes

  • Percent of patient days with a low blood glucose, defines as less than 60 mg/dl(200 hours while in ICU)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials